Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Apply zero based budgeting to household expenses to ensure every dollar is assigned, reducing waste and boosting savings.
18,110 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
When a figure headlines with trillionaire status and a big stock sale, investors want to know what it means for the s...
Markets show a three-way dance: oil slides, gold falters, and stocks barely move as Alphabet makes its Dow debut. Her...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
This year brought a sharp retreat in Accenture’s stock. The drop isn’t just a price move—it's a signal. This guide br...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
A domestic sting underscores how easily scams prey on seniors. Explore how the scheme worked, the red flags to watch ...
As quantum tech hits the investing stage, two very different bets stand out: IonQ Quantum Computing Inc. and Quantum ...
Solana continues a stubborn rebound, trading in the upper-$80s as traders eye a move past $100 and toward $120. On-ch...
SpaceX is fueling ambitious AI bets with a massive cash runway. This article weighs that plan against two established...
Two funds sit at the edge of space: ARKX and PPA. This guide breaks down what each ETF targets, how they differ, and ...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...